Skip to main content

Diflorasone Diacetate

Generic: DIFLORASONE DIACETATE

Verified·Apr 23, 2026
NDC
51672-1295
ICD-10 indication
L30.9

Affordability Check

How much will you actually pay for Diflorasone Diacetate?

In 30 seconds, see every legitimate way to afford Diflorasone Diacetate — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Diflorasone Diacetate

What is this medication?

Diflorasone diacetate is a high-potency topical corticosteroid used to treat various inflammatory skin conditions. It works by activating natural substances in the skin to reduce swelling, redness, and itching. This medication is classified as a potent corticosteroid, making it an effective option for managing dermatological issues that involve significant irritation or immune responses in the skin tissue.

Physicians commonly prescribe this medication for the relief of symptoms associated with psoriasis, atopic dermatitis, and severe cases of contact dermatitis. It is typically applied as a cream or ointment directly to the affected area to manage chronic flare-ups and provide relief from persistent itching. Because of its strength, it is generally used for specific periods as directed by a healthcare provider to minimize the risk of side effects.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Diflorasone Diacetate. Official source: DailyMed (NLM) · Label effective Jul 3, 2025

Indications and usage
INDICATIONS AND USAGE Topical corticosteroids are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and administration
DOSAGE AND ADMINISTRATION Diflorasone diacetate ointment should be applied to the affected area as a thin film from one to three times daily depending on the severity or resistant nature of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
Contraindications
CONTRAINDICATIONS Topical steroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse reactions
ADVERSE REACTIONS The following local adverse reactions have been reported with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneiform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria
Use in pregnancy
Pregnancy Category C Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Diflorasone Diacetate appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

7%

402 of 5,509 plans

Most common tier

Tier 4

On 65% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)5
29%
Tier 2 (generic)1
6%
Tier 4 (non-preferred brand)11
65%

Step therapy: 0% of formularies

Quantity limits: 65% of formularies

Coverage breadth: 17 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.